228 related articles for article (PubMed ID: 23760658)
1. Mathematical model of the roles of T cells in inflammatory bowel disease.
Lo WC; Arsenescu RI; Friedman A
Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
[TBL] [Abstract][Full Text] [Related]
2. Th9 cells in inflammatory bowel diseases.
Weigmann B; Neurath MF
Semin Immunopathol; 2017 Jan; 39(1):89-95. PubMed ID: 27837255
[TBL] [Abstract][Full Text] [Related]
3. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
[TBL] [Abstract][Full Text] [Related]
4. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases.
Carrasco A; Fernández-Bañares F; Pedrosa E; Salas A; Loras C; Rosinach M; Aceituno M; Andújar X; Forné M; Zabana Y; Esteve M
J Crohns Colitis; 2016 Sep; 10(9):1042-54. PubMed ID: 26995182
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
Rovedatti L; Kudo T; Biancheri P; Sarra M; Knowles CH; Rampton DS; Corazza GR; Monteleone G; Di Sabatino A; Macdonald TT
Gut; 2009 Dec; 58(12):1629-36. PubMed ID: 19740775
[TBL] [Abstract][Full Text] [Related]
6. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
7. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
[TBL] [Abstract][Full Text] [Related]
8. The role of mucosal T lymphocytes in regulating intestinal inflammation.
Uhlig HH; Powrie F
Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
[TBL] [Abstract][Full Text] [Related]
9. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
[TBL] [Abstract][Full Text] [Related]
10. Signaling for inflammation and repair in inflammatory bowel disease.
Neuman MG
Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
[TBL] [Abstract][Full Text] [Related]
11. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
Vyas SP; Goswami R
Front Immunol; 2018; 9():1139. PubMed ID: 29881387
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in inflammatory bowel disease.
Kmieć Z
Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
[TBL] [Abstract][Full Text] [Related]
13. Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease.
Lawrance IC
Expert Opin Investig Drugs; 2012 Jul; 21(7):975-84. PubMed ID: 22612537
[TBL] [Abstract][Full Text] [Related]
14. [The cytokines in inflammatory bowel disease].
Polińska B; Matowicka-Karna J; Kemona H
Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
[TBL] [Abstract][Full Text] [Related]
15. Functional plasticity of Th17 cells: implications in gastrointestinal tract function.
Garrido-Mesa N; Algieri F; Rodríguez Nogales A; Gálvez J
Int Rev Immunol; 2013; 32(5-6):493-510. PubMed ID: 24040751
[TBL] [Abstract][Full Text] [Related]
16. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
Dignass AU; Baumgart DC; Sturm A
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
[TBL] [Abstract][Full Text] [Related]
17. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
Di Sabatino A; Rovedatti L; Kaur R; Spencer JP; Brown JT; Morisset VD; Biancheri P; Leakey NA; Wilde JI; Scott L; Corazza GR; Lee K; Sengupta N; Knowles CH; Gunthorpe MJ; McLean PG; MacDonald TT; Kruidenier L
J Immunol; 2009 Sep; 183(5):3454-62. PubMed ID: 19648266
[TBL] [Abstract][Full Text] [Related]
18. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders.
Zundler S; Neurath MF
Immunol Rev; 2017 Jul; 278(1):263-276. PubMed ID: 28658546
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
Neurath MF
Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
